...
首页> 外文期刊>Gastrointestinal Endoscopy >Newly designed stent for endoscopic bilateral stent-in-stent placement of metallic stents in patients with malignant hilar biliary strictures: multicenter prospective feasibility study (with videos).
【24h】

Newly designed stent for endoscopic bilateral stent-in-stent placement of metallic stents in patients with malignant hilar biliary strictures: multicenter prospective feasibility study (with videos).

机译:新设计的支架用于在恶性肝门胆管狭窄患者内镜下双侧支架置入金属支架:多中心前瞻性可行性研究(带视频)。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Endoscopic management of malignant hilar biliary strictures is difficult even for an experienced endoscopist. Moreover, endoscopic placement of bilateral metal stents is considered very difficult and complicated. OBJECTIVE: We explored the feasibility and efficacy of the placement of a newly designed metal stent for an endoscopic bilateral stent-in-stent procedure for the management of malignant hilar biliary strictures. DESIGN: Multicenter prospective feasibility study. SETTING: Five academic tertiary referral centers. PATIENTS: Thirty-five patients with malignant hilar biliary strictures of Bismuth type II or higher were enrolled. INTERVENTIONS: Bilateral stent placement by an endoscopic stent-in-stent procedure. MAIN OUTCOME MEASUREMENTS: Technical success, functional success, early and late complications, stent patency. RESULTS: The overall technical success rate of the newly designed metal stent was 94.3% (33/35). The success rate of the stent-in-stent procedure in a single session was 82% (27/33) per protocol and 77% (27/35) as intent to treat. In cases in which the initial stent-in-stent procedure failed, patients underwent the endoscopic stent-in-stent procedure for contralateral stent placement at 2 days (6%, 2/33) or 4 days (12%, 4/33) after the initial stent placement. There was no percutaneous insertion of a contralateral stent in these patients. There was no stent-related early or late complication in any enrolled patient. Functional success was 100% (33/33). Reintervention because of stent malfunction was 6% (2/33). These 2 patients showed sludge formation in the stent. During follow-up, there was no stent tumor ingrowth or overgrowth in the placed stent in any enrolled patient. According to the Kaplan-Meier analysis, median survival and stent patency were 180 days and 150 days, respectively. LIMITATIONS: An uncontrolled feasibility study with a small patient population and a limited follow-up period. CONCLUSION: The newly designed metal stent for the endoscopic bilateral stent-in-stent procedure may be feasible and effective for malignant hilar biliary strictures.
机译:背景:即使有经验的内镜医师也很难在内镜下治疗恶性肝门胆管狭窄。此外,内窥镜放置双侧金属支架被认为是非常困难和复杂的。目的:我们探讨了一种新设计的金属支架置入内镜下双侧支架内手术治疗恶性肝门胆管狭窄的可行性和有效性。设计:多中心前瞻性可行性研究。地点:五个学术大学转介中心。患者:35例患有Bismuth II型或更高级别的恶性肝门胆管狭窄的患者入选。干预:通过内窥镜支架置入术进行双侧支架置入。主要观察指标:技术成功,功能成功,早期和晚期并发症,支架通畅。结果:新设计的金属支架的整体技术成功率为94.3%(33/35)。每个方案中,支架内支架手术的成功率为每个方案82%(27/33),治疗意图为77%(27/35)。如果初始支架植入手术失败,则在第2天(6%,2/33)或第4天(12%,4/33)对患者进行对侧支架置入的内窥镜支架手术初始支架放置后。这些患者中没有经皮插入对侧支架。所有入组患者均无支架相关的早期或晚期并发症。功能成功率为100%(33/33)。由于支架故障而进行的再干预率为6%(2/33)。这2例患者在支架中显示出淤泥形成。在随访期间,所有入组患者中放置的支架均无支架肿瘤向内生长或过度生长。根据Kaplan-Meier分析,中位生存期和支架通畅时间分别为180天和150天。局限性:一项不受控制的可行性研究,患者人数少,随访时间有限。结论:新设计的内镜下双侧支架置入术金属支架对于恶性肝门胆管狭窄可能是可行和有效的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号